We Are A Global Leader In
Innovative Clinical Drug Development
Leading The Way With Innovative Medical Treatments
DELTA HEALTH is a global healthcare company focused on providing a comprehensive portfolio of innovative clinical drug development expertise and dedicated clinical trial site management.
We have been assisting partners in the healthcare sector optimize and develop reformulated drug products, new chemical entities, biologics, vaccines and medical devices that aim to offer advanced therapies and an improvement to available patient care.
Initially starting with the operation of a group of successful clinical trial investigative sites at the time of embarking on its journey more than two decades back, DELTA HEALTH has progressively evolved and diversified its capabilities in the clinical drug development arena.
With a time-tested proven track record spanning over 20 years, the highly talented and experienced specialists of our team have lead full clinical development programs that have resulted in successful regulatory approval of a number of prescription drug products from the United States Food and Drug Administration (FDA), Health Canada and other international agencies.
The DELTA HEALTH team of dedicated clinical drug development professionals and Clinical Trial Investigators includes physicians, U.S. Board Certified Medical Specialists, U.K. General Medical Council Specialists and drug safety experts. The clinical development and drug safety groups have deep knowledge of legislation and broad based experience of the healthcare industry giving them the flexibility to work in major regions around the world.
Our Board and Advisory Groups include prestigious names in healthcare, including physicians on the faculty of major hospitals in the United States, Canada and the National Institutes of Health (NIH), Bethesda, MD.
We are also one of the privileged few in the healthcare industry having extensive experience with direct
in-person interaction and successful working collaboration with the US FDA and Health Canada.